Clinical trial
Intermittent Antimalaria Treatment With SP in African Children
NCT00168948 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00168948 |
|---|---|
| Title | Intermittent Antimalaria Treatment With SP in African Children |
| Official title | Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Collaborators | Deutscher Akademischer Austausch Dienst |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, Anemia |
| Intervention type | Drug |
| Interventions | Sulfadoxin (12.5) Pyrimethamine (250 mg) |
| Enrollment | 1,200 |
| Start date | Mar 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 2, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: